South China Morning Post CENTER (0.0) Reliability: 7.5/10

China investors energise Hong Kong biotech stocks. Is foreign money missing out?

✍️ Julie Zhang 📅 March 10, 2026 07:30 AM ⏱️ 1 min read 🕐 Scraped: March 10, 2026

Summary: Stock Connect reshuffle reflects biotech sector’s growing role on international stage, though overseas funds remain cautious.

Mainland Chinese investors can now buy shares in more than a dozen newly added Hong Kong-listed biotech and pharmaceutical companies after a reshuffle of the Stock Connect southbound trading list took effect on Monday, reflecti

📰

Continue Reading on South China Morning Post

This preview shows approximately 15% of the article. Read the full story on the publisher's website to support quality journalism.

Read Full Article →

How do you feel about this article?

Read Original Article →

📝 Article Information

Author

Julie Zhang

Original Publisher

🌍 South China Morning Post

CENTER Bias (0.0)

Published Date

March 10, 2026 at 07:30 AM

ℹ️

Disclaimer

ArkforgeAI.com - Newsource is a news aggregation platform. We do not create, write, or produce original news content. All articles are sourced from their respective publishers and remain the property of their original creators. We analyze and aggregate news from multiple sources to provide diverse perspectives across the political spectrum.

The content displayed here is for informational purposes only. For the complete and original article, please visit the source's website using the "Read Original Article" link above.